Sanara MedTech Inc. Segments Disclosure
NOTE 15 – SEGMENT REPORTING
On September 2, 2025, the Company announced that Seth Yon, its President and Chief Commercial Officer was appointed to the position of President and Chief Executive Officer, effective September 15, 2025. The Company’s Chief Executive Officer is the chief operating decision maker (the “CODM”). The CODM reviews operating results and makes decisions about resource allocation. As described in Note 1, the THP segment met the accounting requirements to be classified as discontinued operations at September 30, 2025, and the Company no longer reports the THP segment. Accordingly, the Company has one reportable segment. The determination that the Company operates as a single segment is consistent with the nature of its operations and the financial information regularly reviewed by the Company’s CODM.
Net income (loss) is the primary profitability measure used by the CODM for purposes of assessing financial performance and resource allocation. In addition to net income (loss), the CODM also uses Adjusted EBITDA for purposes of assessing financial performance and resource allocation. Adjusted EBITDA is a non-GAAP measure and is defined as net income (loss) excluding interest expense/income, provision/benefit for income taxes, depreciation and amortization, noncash share-based compensation expense, change in fair value of earnout liabilities, asset impairment charges, share of losses from equity method investments, executive separation costs, legal and diligence expenses related to acquisitions, asset impairment charges and gains/losses on disposal of property and equipment, as each are applicable to the periods presented. Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. The CODM also reviews budget-to-actual variances for expenses on a monthly basis when making decisions about allocating resources to the segment. The measure of segment assets is reported in the Consolidated Balance Sheets as total consolidated assets.
The following table reflects results of operations including significant segment expenses that are regularly provided to the CODM for the Company’s reportable segment and Adjusted EBITDA for the periods presented:
Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| Net revenue | $ | 103,117,982 | $ | 86,672,425 | ||||
| Cost of goods sold | 7,520,969 | 8,139,901 | ||||||
| General and administrative | 16,706,206 | 15,385,983 | ||||||
| Sales and marketing (1) | 62,010,793 | 56,287,659 | ||||||
| Research and development | 5,072,483 | 2,828,663 | ||||||
| Depreciation and amortization | 2,661,873 | 2,785,829 | ||||||
| Change in fair value of earnout liabilities | (14,451 | ) | ||||||
| Asset impairment charges | 1,841,120 | |||||||
| Other expense (2) | 7,697,662 | 3,196,424 | ||||||
| Net loss from continuing operations | $ | (393,124 | ) | $ | (1,937,583 | ) | ||
| Adjusted EBITDA | $ | 17,013,836 | $ | 9,148,722 | ||||
| (1) | For the years ended December 31, 2025 and 2024, sales and marketing included compensation and benefits, commissions, travel and other sales and marketing expenses. | |
| (2) | For the years ended December 31, 2025 and 2024, other expense included interest expense and share of losses from equity method investments, offset by interest income and gain on disposal of property and equipment. |
The following table provides a reconciliation of net loss from continuing operations to Adjusted EBITDA for the periods presented:
Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| Net loss from continuing operations | $ | (393,124 | ) | $ | (1,937,583 | ) | ||
| Adjustments: | ||||||||
| Interest expense | 6,759,800 | 3,128,395 | ||||||
| Depreciation and amortization | 2,661,873 | 2,785,829 | ||||||
| Noncash share-based compensation | 4,773,982 | 3,969,008 | ||||||
| Change in fair value of earnout liabilities | (14,451 | ) | ||||||
| Asset impairment charges | 1,841,120 | |||||||
| Share of losses from equity method investments | 952,466 | 90,007 | ||||||
| Gain on disposal of property and equipment | (10,932 | ) | ||||||
| Interest income | (3,672 | ) | (21,978 | ) | ||||
| Executive separation costs (1) | 432,323 | 964,466 | ||||||
| Acquisition costs (2) | 185,029 | |||||||
| Adjusted EBITDA | $ | 17,013,836 | $ | 9,148,722 | ||||
| (1) | Includes $ and $ of share-based compensation related to executive separation costs for the years ended December 31, 2025 and 2024, respectively. | |
| (2) | Acquisition costs include legal, tax, accounting and other contract services related to prospective acquisitions. |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 24, 2026 | Showing above |
| 2024 | Mar 25, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.